Eyepoint Pharmaceuticals Net Income vs. Profit Margin
| EYPT Stock | USD 8.85 0.20 2.21% |
Net Loss | First Reported 2002-09-30 | Previous Quarter -30.8 M | Current Value -29.4 M | Quarterly Volatility 13.7 M |
For Eyepoint Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eyepoint Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eyepoint Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eyepoint Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eyepoint Pharmaceuticals over time as well as its relative position and ranking within its peers.
Eyepoint |
Eyepoint Pharmaceuticals' Revenue Breakdown by Earning Segment
Check out Investing Opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyepoint Pharmaceuticals. If investors know Eyepoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyepoint Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.99) | Revenue Per Share 0.902 | Quarterly Revenue Growth (0.31) | Return On Assets (0.31) | Return On Equity (0.75) |
The market value of Eyepoint Pharmaceuticals is measured differently than its book value, which is the value of Eyepoint that is recorded on the company's balance sheet. Investors also form their own opinion of Eyepoint Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eyepoint Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyepoint Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eyepoint Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyepoint Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyepoint Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyepoint Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eyepoint Pharmaceuticals Profit Margin vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Eyepoint Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Eyepoint Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Eyepoint Pharmaceuticals is rated below average in net income category among its peers. It is rated below average in profit margin category among its peers . At this time, Eyepoint Pharmaceuticals' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Eyepoint Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Eyepoint Profit Margin vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Eyepoint Pharmaceuticals |
| = | (70.8 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Eyepoint Pharmaceuticals |
| = | (2.27) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Eyepoint Profit Margin Comparison
Eyepoint Pharmaceuticals is currently under evaluation in profit margin category among its peers.
Eyepoint Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Eyepoint Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eyepoint Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Eyepoint Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Eyepoint Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 864 K | 1.2 M | |
| Operating Income | -75.1 M | -71.3 M | |
| Income Before Tax | -70.7 M | -67.2 M | |
| Total Other Income Expense Net | 4.4 M | 4.6 M | |
| Net Loss | -70.8 M | -67.3 M | |
| Income Tax Expense | 83 K | 87.2 K | |
| Net Loss | -92 M | -87.4 M | |
| Net Loss | -70.8 M | -67.3 M | |
| Non Operating Income Net Other | 514.8 K | 540.5 K | |
| Net Interest Income | 5.7 M | 6 M | |
| Interest Income | 6.9 M | 3.8 M | |
| Change To Netincome | 44.1 M | 46.3 M | |
| Net Loss | (1.82) | (1.91) | |
| Income Quality | (0.03) | (0.03) | |
| Net Income Per E B T | 1.00 | 0.75 |
Eyepoint Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Eyepoint Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eyepoint Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eyepoint Pharmaceuticals' important profitability drivers and their relationship over time.
Use Eyepoint Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyepoint Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyepoint Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Eyepoint Pharmaceuticals Pair Trading
Eyepoint Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Eyepoint Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyepoint Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyepoint Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyepoint Pharmaceuticals to buy it.
The correlation of Eyepoint Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyepoint Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyepoint Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eyepoint Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Eyepoint Pharmaceuticals position
In addition to having Eyepoint Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.